Last week JDRF launched the Artificial Pancreas Campaign. Now, they need your help. Will you sign a petition to the Food and Drug Administration (FDA)? The goal of the initiative is to convince the FDA to adopt the recommendations of clinical experts to advance the development of an artificial pancreas, a device which has the potential to be the most revolutionary advancement in the treatment of T1D since the discovery of insulin. The petition will be presented to the FDA and leading Members of Congress to demonstrate the enormous support for accelerated progress on making a safe and effective artificial pancreas available in America as soon as possible. FDA obstacles have already prevented Americans affected by T1D from using the low glucose suspend (LGS) insulin pump, a precursor to the artificial pancreas. Meanwhile, patients in over 40 other countries, including Canada, England, France, and Germany, can obtain the LGS device. The artificial pancreas will do more than just help those living with diabetes. If widely adopted, the artificial pancreas will help address our nation’s spiraling medical costs, saving Medicare nearly $2 billion over 25 years.
To sign the petition, click here.